Robbie Marcus
Stock Analyst at JP Morgan
(3.93)
# 606
Out of 4,944 analysts
163
Total ratings
55.45%
Success rate
8.23%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Downgrades: Neutral | $195 → $110 | $87.36 | +25.92% | 6 | Aug 5, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $80 → $85 | $77.68 | +9.42% | 5 | Jul 25, 2025 | |
| COO The Cooper Companies | Downgrades: Neutral | $110 → $76 | $74.27 | +2.33% | 5 | May 30, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $14 → $16 | $9.32 | +71.67% | 5 | May 14, 2025 | |
| CVRX CVRx, Inc. | Downgrades: Underweight | $15 → $7 | $7.73 | -9.44% | 6 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Overweight | $128 → $105 | $103.22 | +1.72% | 6 | May 6, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underweight | $24 → $12 | $14.12 | -15.01% | 6 | May 6, 2025 | |
| CNMD CONMED | Maintains: Neutral | $70 → $58 | $55.19 | +5.09% | 7 | May 1, 2025 | |
| RXST RxSight | Downgrades: Underweight | $40 → $17 | $8.31 | +104.57% | 5 | Apr 4, 2025 | |
| MMSI Merit Medical Systems | Initiates: Overweight | $120 | $86.15 | +39.29% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $24.11 | +49.32% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $445 | $378.95 | +17.43% | 9 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $482.35 | +39.94% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $7.53 | +72.64% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $102.50 | +7.32% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $308.68 | +6.91% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $11.94 | +168.12% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $36.70 | +8.99% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $85 | $79.96 | +6.30% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $75.33 | +19.47% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $29.59 | +68.98% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $6.90 | +15.94% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $257.38 | -2.87% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $16 | $18.85 | -15.12% | 3 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $7.77 | -9.85% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $17 | $14.17 | +19.97% | 2 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $129.40 | -8.81% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $166.86 | -6.51% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $130 → $105 | $92.91 | +13.01% | 11 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $91.79 | -56.42% | 2 | May 5, 2020 |
Inspire Medical Systems
Aug 5, 2025
Downgrades: Neutral
Price Target: $195 → $110
Current: $87.36
Upside: +25.92%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $80 → $85
Current: $77.68
Upside: +9.42%
The Cooper Companies
May 30, 2025
Downgrades: Neutral
Price Target: $110 → $76
Current: $74.27
Upside: +2.33%
NeuroPace
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $9.32
Upside: +71.67%
CVRx, Inc.
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $7.73
Upside: -9.44%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Overweight
Price Target: $128 → $105
Current: $103.22
Upside: +1.72%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Underweight
Price Target: $24 → $12
Current: $14.12
Upside: -15.01%
CONMED
May 1, 2025
Maintains: Neutral
Price Target: $70 → $58
Current: $55.19
Upside: +5.09%
RxSight
Apr 4, 2025
Downgrades: Underweight
Price Target: $40 → $17
Current: $8.31
Upside: +104.57%
Merit Medical Systems
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $86.15
Upside: +39.29%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $24.11
Upside: +49.32%
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $378.95
Upside: +17.43%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $482.35
Upside: +39.94%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $7.53
Upside: +72.64%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $102.50
Upside: +7.32%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $308.68
Upside: +6.91%
Nov 5, 2024
Initiates: Overweight
Price Target: $32
Current: $11.94
Upside: +168.12%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $36.70
Upside: +8.99%
Oct 25, 2024
Maintains: Neutral
Price Target: $75 → $85
Current: $79.96
Upside: +6.30%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $75.33
Upside: +19.47%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $29.59
Upside: +68.98%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $6.90
Upside: +15.94%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $257.38
Upside: -2.87%
Dec 20, 2023
Maintains: Neutral
Price Target: $10 → $16
Current: $18.85
Upside: -15.12%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $7.77
Upside: -9.85%
Feb 23, 2023
Maintains: Neutral
Price Target: $15 → $17
Current: $14.17
Upside: +19.97%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $129.40
Upside: -8.81%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $166.86
Upside: -6.51%
Dec 17, 2021
Downgrades: Neutral
Price Target: $130 → $105
Current: $92.91
Upside: +13.01%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $91.79
Upside: -56.42%